Curexo logo

Curexo

Curexo is a South Korean maker of the CUVIS-joint knee replacement robot, the CUVIS-spine navigation robot, and the MorningWalk gait rehabilitation robot. Revenue was 74.5 billion won in 2025, an estimated $52 million, up 34 percent, and the company returned to an operating profit.7,8

Robotics Reviewed Editorial TeamUpdated November 13, 2026curexo.com

Our take

Curexo sells CUVIS-joint, a robot that cuts bone automatically for total knee replacement, and CUVIS-spine, a navigation robot for spinal screw placement. It also makes the MorningWalk gait rehabilitation robot.4,5,2

It suits hospitals that want a fully automatic knee robot that is not tied to one implant maker. Its medical robot sales grew 88 percent in 2025, mostly outside the United States.8,4

Scores by criterion

Curexo scores out of 10
Pricing transparency3.0
Product maturity7.5
Deployment evidence7.0
Company durability6.5
Ease of integration6.5
Overall score (average of the five)6.1

Pricing transparency, 3.0: Curexo publishes no system or per-case prices.4

Product maturity, 7.5: Curexo bought the robotics assets of ROBODOC from IBM and ISS in 2007 and Hyundai Heavy Industries' medical robot unit in 2017. CUVIS-spine received U.S. FDA 510(k) clearance in 2021.2,1

Deployment evidence, 7.0: Curexo has installed more than 100 CUVIS-joint systems and launched CUVIS-joint in Korea and India and CUVIS-spine in Korea, the United States, and Australia.3

Company durability, 6.5: Revenue rose 34 percent to 74.5 billion won in 2025, with an operating profit of 2.4 billion won after losses. Food distribution still made up about a third of revenue.7,8

Ease of integration, 6.5: CUVIS-joint is sold as an open platform that works with several implant makers, but a cutting robot still changes the operating room workflow.4

Each criterion is defined on our methodology page.

Who uses Curexo and what it's for

The buyer is a hospital or orthopedic group that wants an automatic knee replacement robot, or a spine program that wants navigation for screw placement.4,5

Buyers should compare it with Stryker Mako, THINK Surgical, Globus Medical ExcelsiusGPS, and TINAVI.

Surgical and rehabilitation robots

CUVIS-joint plans the knee replacement and then cuts the bone automatically. Curexo calls it an open platform because it works with implants from several makers.4

CUVIS-spine guides pedicle screw placement in spine surgery, and MorningWalk is a gait rehabilitation robot used in hospitals in Korea and shown in Japan.5,6

Deployments and approvals

Curexo lists more than 100 CUVIS-joint installations, FDA 510(k) clearance for CUVIS-spine, and launches in Korea, India, the United States, and Australia.3,1

Medical robot revenue rose 88 percent to 36.4 billion won in 2025 as exports widened.8

Pricing

Curexo does not publish prices.4

Company, ownership, and revenue

Curexo was founded in 2006 and is listed on KOSDAQ. hy, formerly Korea Yakult, is its main shareholder.2,3

Consolidated revenue was 74.5 billion won in 2025, including 36.4 billion won from medical robots, 12.6 billion won from implants, and 25.6 billion won from food distribution.7,8

Competitive landscape

Which of these companies scores best, and who is each one built for?Hover over or tap a logo for details.
Top rated, for smaller operationsTop rated, for large enterprisesLower score, for smaller operationsLower score, for large enterprisesNot yet reviewed45678910Review Score← Smaller operationsLarge enterprises →Who it's built for6.17.56.85.9
Curexo and its competitors
CompanyProductPricing modelDeployment footprintWhere Curexo wins or loses
CurexoCUVIS-joint fully automatic knee robot, CUVIS-spine navigation, MorningWalk4Quote4More than 100 CUVIS-joint installs; Korea, India, US, Australia launches3Korean knee and spine robot maker; profitable in 2025
Stryker Mako SmartRoboticsMako 4 with CT planning and AccuStop haptics10Quote; no prices published10More than two million procedures in more than 45 countries9Mako wins on the largest installed base in knee and hip replacement. Curexo wins on fully automatic bone cutting on an open implant platform.
THINK Surgical TMINIHandheld, wireless knee robot with TPLAN planning12Quote; demo by request125,000 procedures by May 202612THINK Surgical wins on a handheld knee robot with an open implant library. Curexo wins on fully automatic bone cutting on an open implant platform.
Globus Medical ExcelsiusGPSRigid arm plus full navigation, CT or fluoroscopy14Quote; spec sheet by request14141.0 million dollars of enabling technology sales in 202513ExcelsiusGPS wins on spine navigation tied to a big implant catalog. Curexo wins on fully automatic bone cutting on an open implant platform.
TINAVITiRobot II for spine, trauma, and joint surgery18Quote; no prices published18More than 180,000 cases at more than 200 hospitals15TINAVI wins on trauma and spine coverage at a lower price in China. Curexo wins on fully automatic bone cutting on an open implant platform.
eCential RoboticsImaging, navigation, and robotics in one platform17Quote; demo by request17More than 3,500 surgeries17eCential wins on combined imaging, navigation, and robotics for spine. Curexo wins on fully automatic bone cutting on an open implant platform.

Limits

No published prices.4

A large share of revenue still comes from non-robot food distribution.8

Smaller U.S. presence than Stryker or Globus.3

What customers say

Where it helps

A fully automatic knee cutting robot on an open implant platform.4

Where it falls short

Thin profits so far.7

Leadership

Sources